Basking: Science firm linked to Duke professor raises $27M for stroke treatment
A drug company with ties to Duke University has raised fresh capital as it develops a treatment for strokes.
Read full article »
Basking is an Ohio-based clinical-stage biopharmaceutical company that researches and develops novel acute thrombolytic therapies for the treatment of acute thrombosis.
Read more